Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin

Arthritis and Rheumatology

Volumn 67, Issue 12, 2015, Pages 3190-3200

  Wang, Haiting ^a   Li, Ting ^a   Chen, Sheng ^a   Gu, Yueying ^a   Ye, Shuang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METFORMIN; MITOCHONDRIAL DNA; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISONE; ANTIDIABETIC AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA; IMMUNOGLOBULIN G; INTERFERON;

ADD ON THERAPY; ADULT; ANTIBODY DETECTION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY SCORE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; EX VIVO STUDY; EXTRACELLULAR TRAP; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; CASE CONTROL STUDY; DENDRITIC CELL; DOWN REGULATION; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEUTROPHIL; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; DENDRITIC CELLS; DNA; DNA, MITOCHONDRIAL; DOWN-REGULATION; EXTRACELLULAR TRAPS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOGLOBULIN G; IN VITRO TECHNIQUES; INTERFERON TYPE I; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; METFORMIN; MIDDLE AGED; NEUTROPHILS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84948398534     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39296     Document Type: Article

References (33)

1. Wahren-Herlenius M, Dorner T., Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013; 382: 819-31.
2. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra20.
3. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 2011; 3: 73ra19.
4. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L, et al., FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J Immunol 2003; 171: 3296-302.
5. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD., Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115: 407-17.
6. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU., Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 2009; 16: 1438-44.
7. Cardon LR, Burge C, Clayton DA, Karlin S., Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci U S A 1994; 91: 3799-803.
8. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-5.
9. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001; 98: 9237-42.
10. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al., Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-7.
11. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F., Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122: 253-70.
12. Mahmood K, Naeem M, Rahimnajjad NA., Metformin: the hidden chronicles of a magic drug. Eur J Intern Med 2013; 24: 20-6.
13. Brinkmann V, Zychlinsky A., Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007; 5: 577-82.
14. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al., Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-41.
15. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
17. Isenberg DA, Gordon C., From BILAG to BLIPS-disease activity assessment in lupus past, present and future. Lupus 2000; 9: 651-4.
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
19. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al., The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30.
20. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al, for the OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550-8.
21. Petri M, Buyon J, Kim M., Classification and definition of major flares in SLE clinical trials. Lupus 1999; 8: 685-91.
22. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, et al., Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3958-67.
23. Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senecal JL, Cividino A, et al, the Canadian Hydroxychloroquine Study Group. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. Lupus 1998; 7: 80-5.
24. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al., Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010; 107: 9813-8.
25. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 504-9.
26. Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, et al., Peptidylargininedeiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 2013; 123: 2981-93.
27. Simon HU, Haj-Yehia A, Levi-Schaffer F., Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 2000; 5: 415-8.
28. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al., Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538-52.
29. Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S., Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 2009; 182: 8005-14.
30. Kalariya NM, Shoeb M, Ansari NH, Srivastava SK, Ramana KV., Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2012; 53: 3431-40.
31. Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K., Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther 2010; 334: 206-13.
32. Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, et al., Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells. Arterioscler Thromb Vasc Biol 2006; 26: 611-7.
33. Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP, et al., Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med 2015; 7: 274ra18.